Guocai's contract renewal rules are here, officially released by the Medical Insurance Bureau

On November 4, the Medical Insurance Bureau issued the "Notice on Doing a Good Job in the Continuation of the State-Organized Drug Centralized Purchase Agreement after the Expiry", which stipulates the selection rules for the renewal of centralized procurement
.

 

The following is the text of the notice:

 

The medical insurance bureaus of all provinces, autonomous regions, municipalities directly under the Central Government and Xinjiang Production and Construction Corps:

 

In order to implement the "Opinions of the General Office of the State Council on Promoting the Normalized and Institutionalized Development of Drug Centralized and Volume Procurement" (Guobanfa [2021] No.
2), consolidate the achievements of the state-organized centralized drug procurement reform and achieve stability after the expiration of the procurement agreement Continuing, the relevant work requirements are hereby notified as follows
.

 

1.
Attach great importance to the work of continuing after the expiry of the agreement

 

The smooth implementation of the continuation work after the expiration of the state-organized centralized drug procurement agreement (hereinafter referred to as "continuation work?") is to implement the decision and deployment of the Party Central Committee and the State Council on the reform of the centralized drug procurement system, and promote the normalized and institutionalized operation of centralized procurement Important link
.
All localities must fully understand the importance of doing this work well, conscientiously unify their thoughts and actions into the decision-making and deployment of the Party Central Committee, adhere to the people-centered principle, adhere to the principle of “integration of recruitment and procurement, linking quantity and price”, and align the direction of reform.
, Focusing on stabilizing market expectations, stabilizing price levels, and stabilizing clinical use, with provinces (autonomous regions, municipalities directly under the Central Government, and Xinjiang Production and Construction Corps) or inter-provincial alliances as units, comply with laws and regulations, carry out continuity work steadily, and guide the society to form long-term stable expectations
.

 

2.
Do a good job in connection

 

(1) Persist in purchasing in quantity
.
In principle, all national organizations should continue to carry out centralized procurement with volume after the expiration of the agreement on centralized procurement of drugs
.
Holders of the original research drugs, reference preparations, and drug marketing licenses that have passed the quality and efficacy consistency evaluation of generic drugs can all participate
.
The medical institution shall report the demand for the drugs to be purchased in combination with the actual usage of the previous year, the clinical usage status, and the advancement of medical technology
.
The medical insurance department summarizes the total demand submitted by the medical institution, and determines the agreed purchase amount based on the proportion of the amount.
In principle, it shall not be less than the agreed purchase amount of the previous year
.
For medical institutions whose reporting requirements are significantly lower than the previous year's purchases, they should be required to provide explanations and increase supervision over their purchases
.
The rules for the allocation of procurement volume should be clearly agreed in advance to ensure that the agreed procurement volume is allocated to each selected company and each medical institution
.

 

　　 (2) Carry out continuation by classification
.
Focusing on maintaining the stability of the market and clinical medication, comprehensively considering the various factors of enterprises and products, and determining the selected enterprises and prices through inquiry, bidding, and comprehensive evaluation
.

 

　　1.
For the varieties selected in the previous round of centralized procurement, in principle, the inquiry will be carried out on the basis of a stable price level and clinical use
.
If the price in the last round of the province where the province is selected is not higher than 1.
5 times the lowest price in the country, the price in the last round of the province is used as the baseline to inquire all eligible companies; the price in the last round of the province where the price is higher than the lowest price in the country If the price is 1.
5 times, an inquiry will be conducted to all eligible enterprises based on the baseline of 1.
5 times the lowest selected price in the country
.
The upper limit of the inquiry is the highest selected price in the country in the previous round
.
The selected company and the price of the selected company can be determined according to the company's willingness to quote and combine the results of the comprehensive evaluation of the company and its products
.

 

　　2.
If the inquiry is unsuccessful, or the result of the selection was produced in the last round of centralized procurement, or the actual sales price of the non-selected products in the current market is significantly lower than the lowest selected price in the province in the previous round of centralized procurement and there is actual supply, The selected companies and the selected prices can be reproduced through bidding
.

 

　　Provinces with large demand or high supply guarantee requirements are encouraged to select the same product from multiple companies, and the price difference between different selected companies should be fair and reasonable
.
According to the principle of quantity-price linkage, clarify the agreed procurement volume of each selected company
.
The purchase agreement period can be determined by referring to the relevant rules of the national organization of centralized drug procurement, and the procurement cycle can be adjusted appropriately to gradually unify the execution time of different centralized procurement batches
.
Encourage the comprehensive evaluation of the company's supply, contract performance, product quality , and clinical response
.

 

　　 (3) Strengthen credit and performance evaluation
.
Integrate credit evaluation and contract performance into the main links of the continuation rules, so that it can play a substantive role in the enterprise's application qualification, selection qualification, selection order, and supply area selection
.
Where a comprehensive evaluation method is used to determine the selected enterprise, each province should incorporate the enterprise’s credit evaluation and contract performance into the comprehensive evaluation factors and give it a higher weight
.
Yet integrated assessment should medicine prices and strokes in the case of a credit rating company one of the important short-listed, under the same circumstances, a good credit rating of corporate priorities selected
.
For companies that have been selected in the previous round, if the comprehensive evaluation results or the credit and contract performance are good, they can be given priority in the succession work; if the credit and contract performance are poor, they should be punished in the succession rules
.
If the declared enterprise is included in the “violation list” by the National Organization for Drug Purchasing Office or recognized as untrustworthy to varying degrees by the province where it is located, it can take measures such as shifting the selected order, reducing the proportion of the quantity, and reducing the supply area according to the regulations, until Suspend its eligibility to participate in the succession
.

 

　　 (4) Improve supporting policies
.
Continue to implement the prepayment of medical insurance funds to reduce the pressure on medical institutions to pay back
.
We will improve the rules for centrally sourced varieties to be linked to the Internet, and further coordinate the medical insurance payment standards and the selected prices to effectively enhance the patient's sense of acquisition
.

 

　　 (5) Strengthen the supervision of contract performance
.
Establish and improve the information traceability system of selected drugs to ensure that the selected drugs can be traced in the whole process of production and circulation
.
Carry out monitoring and evaluation on the supply, credit and other aspects of the selected enterprises, consolidate the performance responsibilities, and apply the evaluation results to future centralized procurement work
.
Regularly monitor the purchase, use and payment return of medical institutions to ensure that medical institutions use rationally, give priority to the use of selected products, and return payments in a timely manner
.

 

　　3.
Strengthen organization and implementation

 

　　Local medical security departments should effectively assume the responsibility of overall coordination and supervision, refinement and improvement of the implementation plan in the region, strengthen policy coordination and work cooperation with relevant departments, and carry out continuation work in a timely manner.
Major issues should be reported to the National Medical Security Bureau in a timely manner
.
The National Organization for Pharmaceutical Joint Procurement Office continued to do a good job of daily monitoring and analysis, and urged the implementation of procurement results
.

　　On November 4, the Medical Insurance Bureau issued the "Notice on Doing a Good Job in the Continuation of the State-Organized Drug Centralized Purchase Agreement after the Expiry", which stipulates the selection rules for the renewal of centralized procurement
.

 

　　The following is the text of the notice:

 

　　The medical insurance bureaus of all provinces, autonomous regions, municipalities directly under the Central Government and Xinjiang Production and Construction Corps:

 

　　In order to implement the "Opinions of the General Office of the State Council on Promoting the Normalized and Institutionalized Development of Drug Centralized and Volume Procurement" (Guobanfa [2021] No.
2), consolidate the achievements of the state-organized centralized drug procurement reform and achieve stability after the expiration of the procurement agreement Continuing, the relevant work requirements are hereby notified as follows
.

 

　　1.
Attach great importance to the work of continuing after the expiry of the agreement

 

　　The smooth implementation of the continuation work after the expiration of the state-organized centralized drug procurement agreement (hereinafter referred to as "continuation work?") is to implement the decision and deployment of the Party Central Committee and the State Council on the reform of the centralized drug procurement system, and promote the normalized and institutionalized operation of centralized procurement Important link
.
All localities must fully understand the importance of doing this work well, conscientiously unify their thoughts and actions into the decision-making and deployment of the Party Central Committee, adhere to the people-centered principle, adhere to the principle of “integration of recruitment and procurement, linking quantity and price”, and align the direction of reform.
, Focusing on stabilizing market expectations, stabilizing price levels, and stabilizing clinical use, with provinces (autonomous regions, municipalities directly under the Central Government, and Xinjiang Production and Construction Corps) or inter-provincial alliances as units, comply with laws and regulations, carry out continuity work steadily, and guide the society to form long-term stable expectations
.

 

　　2.
Do a good job in connection

 

　　 (1) Persist in purchasing in quantity
.
In principle, all national organizations should continue to carry out centralized procurement with volume after the expiration of the agreement on centralized procurement of drugs
.
Holders of the original research drugs, reference preparations, and drug marketing licenses that have passed the quality and efficacy consistency evaluation of generic drugs can all participate
.
The medical institution shall report the demand for the drugs to be purchased in combination with the actual usage of the previous year, the clinical usage status, and the advancement of medical technology
.
The medical insurance department summarizes the total demand submitted by the medical institution, and determines the agreed purchase amount based on the proportion of the amount.
In principle, it shall not be less than the agreed purchase amount of the previous year
.
For medical institutions whose reporting requirements are significantly lower than the previous year's purchases, they should be required to provide explanations and increase supervision over their purchases
.
The rules for the allocation of procurement volume should be clearly agreed in advance to ensure that the agreed procurement volume is allocated to each selected company and each medical institution
.

 

　　 (2) Carry out continuation by classification
.
Focusing on maintaining the stability of the market and clinical medication, comprehensively considering the various factors of enterprises and products, and determining the selected enterprises and prices through inquiry, bidding, and comprehensive evaluation
.

 

　　1.
For the varieties selected in the previous round of centralized procurement, in principle, the inquiry will be carried out on the basis of a stable price level and clinical use
.
If the price in the last round of the province where the province is selected is not higher than 1.
5 times the lowest price in the country, the price in the last round of the province is used as the baseline to inquire all eligible companies; the price in the last round of the province where the price is higher than the lowest price in the country If the price is 1.
5 times, an inquiry will be conducted to all eligible enterprises based on the baseline of 1.
5 times the lowest selected price in the country
.
The upper limit of the inquiry is the highest selected price in the country in the previous round
.
The selected company and the price of the selected company can be determined according to the company's willingness to quote and combine the results of the comprehensive evaluation of the company and its products
.

 

　　2.
If the inquiry is unsuccessful, or the result of the selection was produced in the last round of centralized procurement, or the actual sales price of the non-selected products in the current market is significantly lower than the lowest selected price in the province in the previous round of centralized procurement and there is actual supply, The selected companies and the selected prices can be reproduced through bidding
.

 

　　Provinces with large demand or high supply guarantee requirements are encouraged to select the same product from multiple companies, and the price difference between different selected companies should be fair and reasonable
.
According to the principle of quantity-price linkage, clarify the agreed procurement volume of each selected company
.
The purchase agreement period can be determined by referring to the relevant rules of the national organization of centralized drug procurement, and the procurement cycle can be adjusted appropriately to gradually unify the execution time of different centralized procurement batches
.
Encourage the comprehensive evaluation of the company's supply, contract performance, product quality , and clinical response
.

 

　　 (3) Strengthen credit and performance evaluation
.
Integrate credit evaluation and contract performance into the main links of the continuation rules, so that it can play a substantive role in the enterprise's application qualification, selection qualification, selection order, and supply area selection
.
Where a comprehensive evaluation method is used to determine the selected enterprise, each province should incorporate the enterprise’s credit evaluation and contract performance into the comprehensive evaluation factors and give it a higher weight
.
Yet integrated assessment should medicine prices and strokes in the case of a credit rating company one of the important short-listed, under the same circumstances, a good credit rating of corporate priorities selected
.
For companies that have been selected in the previous round, if the comprehensive evaluation results or the credit and contract performance are good, they can be given priority in the succession work; if the credit and contract performance are poor, they should be punished in the succession rules
.
If the declared enterprise is included in the “violation list” by the National Organization for Drug Purchasing Office or recognized as untrustworthy to varying degrees by the province where it is located, it can take measures such as shifting the selected order, reducing the proportion of the quantity, and reducing the supply area according to the regulations, until Suspend its eligibility to participate in the succession
.

 

　　 (4) Improve supporting policies
.
Continue to implement the prepayment of medical insurance funds to reduce the pressure on medical institutions to pay back
.
We will improve the rules for centrally sourced varieties to be linked to the Internet, and further coordinate the medical insurance payment standards and the selected prices to effectively enhance the patient's sense of acquisition
.

 

　　 (5) Strengthen the supervision of contract performance
.
Establish and improve the information traceability system of selected drugs to ensure that the selected drugs can be traced in the whole process of production and circulation
.
Carry out monitoring and evaluation on the supply, credit and other aspects of the selected enterprises, consolidate the performance responsibilities, and apply the evaluation results to future centralized procurement work
.
Regularly monitor the purchase, use and payment return of medical institutions to ensure that medical institutions use rationally, give priority to the use of selected products, and return payments in a timely manner
.

 

　　3.
Strengthen organization and implementation

 

　　Local medical security departments should effectively assume the responsibility of overall coordination and supervision, refinement and improvement of the implementation plan in the region, strengthen policy coordination and work cooperation with relevant departments, and carry out continuation work in a timely manner.
Major issues should be reported to the National Medical Security Bureau in a timely manner
.
The National Organization for Pharmaceutical Joint Procurement Office continued to do a good job of daily monitoring and analysis, and urged the implementation of procurement results
.